(19)
(11) EP 4 430 400 A1

(12)

(43) Date of publication:
18.09.2024 Bulletin 2024/38

(21) Application number: 22814378.0

(22) Date of filing: 09.11.2022
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/57415; G01N 2800/52; G01N 2333/912; G01N 2333/918; G01N 33/57488
(86) International application number:
PCT/EP2022/081262
(87) International publication number:
WO 2023/083863 (19.05.2023 Gazette 2023/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 11.11.2021 EP 21207832

(71) Applicant: Albert-Ludwigs-Universitaet Freiburg
79098 Freiburg (DE)

(72) Inventors:
  • SCHILLING, Oliver
    4052 Basel (CH)
  • STEENBUCK, Derya Ines
    79100 Freiburg (DE)
  • ERBES, Thalia
    79194 Gundelfingen (DE)
  • WEISS, Daniela
    79312 Emmendingen (DE)
  • JAEGER, Markus
    79238 Ehrenkirchen (DE)
  • NOETHLING, Claudia
    79224 Umkirch (DE)

(74) Representative: Kraus & Lederer PartGmbB 
Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) METHOD FOR MONITORING THE RESPONSE TO NEOADJUVANT THERAPY FOR BREAST CANCER